Breaking News: Plummeting Life Expectancy and Accelerating Mortality Rates slammed by Industry Amidst Ongoing Pandemic
Life Expectancy Declining Dramatically, Mortality Rates Increasing Among Covid-19 Vaccinated Population According to Insurance Data
In an eyebrow-raising development, the latest data from the insurance sector indicates that life expectancy is plummeting exponentially among individuals who received mRNA vaccines, long past the pandemic era.
This alarming revelation is sparking a crisis in the insurance industry as the relentless surge in policy claims payouts is crippling profits.
Historically, the insurance industry flaunts a robust reliance on data for survival, with critical risk-based decision-making hinging on precise and accurate information. As such, the industry's data serves as one of the most dependable sources of mortality and disability insights since the pandemic's onset.
The precipitous decline in public health is inciting panic among insurers and spawning significant losses within the stop-loss coverage sector for numerous companies. Employers relying on self-funded schemes are propped up by stop-loss insurance to mitigate the monetary risks of sizeable claims, but escalating medical expenses are incentivizing insurers to shoulder increased payouts, adversely affecting their profitability.
In the wake of this looming disaster, the data also underscores escalating rates of severe diseases, such as cancer and heart failure.
Cigna, a prominent player in the stop-loss insurance market, recently confessed to lower-than-anticipated earnings in the last month. The company conceded that the downturn was precipitated by heightened healthcare expenses, not to mention the burgeoning number of customers who are dying prematurely, alongside ongoing spikes in life-threatening diseases.
In response to these stubborn financial losses, Cigna is now compelled to hike the prices of affected plans in an attempt to salvage dwindling profits.
Elsewhere, Voya Financial executives have vowed to exercise tougher policies in light of relentless claims. Meanwhile, Sun Life Financial's operations in the U.S. are grappling with a surge in extraordinarily priced claims during the fourth quarter, precipitating augmented costs in stop-loss insurance benefits.
Sun Life's president, Dan Fishbein, attributed the upsurge in hefty claims to three potent factors:
- A dramatic surge in the incidence of advanced cancer cases and the exorbitant costs associated with cancer treatments
- An increase in infertility-related issues, fostering the rise of more parents resorting to expensive reproductive techniques
- Increases in the costs of hospital care
In face of these pressing challenges, the company announced it would be raising renewal prices by 14%. Post-renewal, policyholders will have the option to either renew their policies or seek alternative solutions.
Analysts warn that the tumultuous fortunes of these insurance giants may merely hint at an industry-wide pattern developing, wherein insurers increasingly bear the brunt of unexpected, steeply-priced healthcare interventions.
Sheer coincidence, or a telling indicator? A recent Swiss Re Research Institute report contends that the soaring excess mortality rates are likely to persist for another decade.
Excess mortality is a key data point that insurers closely monitor. It refers to the number of deaths that surpass the expected mortality rate under normal conditions. With the widespread inoculation of mRNA vaccines commencing in early 2021, excess deaths surged catastrophically.
The report proposed a worst-case scenario in which elevated mortality persists until 2033, simultaneously departing from pre-pandemic mortality baselines.
The Insurance Collaboration to Save Lives, a nonprofit organization that assesses life insurance claims and fosters proactive screening, testing, and triaging among insurers to minimize excess mortality and morbidity, has pinpointed five unsettling health trends ailing the nation.
According to the organization's founder, Josh Stirling, life expectancy "has deteriorated dramatically over the past decade."
Interestingly, while the underlying causes remain elusive, Stirling identified five trends that have escalated since the advent of the Covid vaccines:
- Cardiac and circulatory: Rates for numerous cardiac and circulatory ailments have skyrocketed by 8-36%.
- Neurological and nervous system: Prevalence rates for several neurological and neurodegenerative diseases have ascended by 16-39%.
- Metabolic and digestive: Incidences of several key metabolic and digestive diseases have swelled by 10-137%.
- Cancer: Cancer rates have surged for numerous types of cancers, except for lung, breast, and colon varieties.
- External Causes: The number of accidents, assaults, and overdoses has risen significantly by 11-30%.
Despite the complex tapestry of potential factors exacerbating these worrying trends, representatives from insurance companies insist on proactive measures to address health deterioration, notably in the domains of cardiac, circulatory, and cancer-related issues.
They emphasize the importance of promoting routine blood pressure checks and prioritized proactive healthcare measures to intervene in underlying health issues contributing to unexpected fatalities in the Covid-vaccinated demographic.
While the ongoing impacts of COVID-19, Long COVID, or immune system alterations may partially account for some of these increases, the exact causes remain intricate, multi-faceted, and incompletely understood.
A research team led by Alessandria et al, and Rodrigues and Andrade posits that mRNA vaccines may be responsible for the disturbing trends observed in the data. A substantial study by Alessandria et al found that mRNA vaccines reduce life expectancy by 37% and exacerbate all-cause mortality risks during a 2-year follow-up period.
In a further blow to the vaccine's reputation, the U.S. Food and Drug Administration (FDA) confessed that individuals who received mRNA vaccines could be susceptible to life-threatening blood clots for up to 15 years post-injection.
This astonishing admission was published in the highly regarded International Journal of Innovative Research in Medical Science and could herald a wave of blood clots in the coming years, as the Covid shots were only publicly distributed approximately four years ago.
“Arguably, we should be back to something close to normal," Stirling says. "But when you look at it by age group, what you see is that it's really quite substantially elevated for younger ages. That's what jumped out at me.”
[Image Caption: Graph displaying excess mortality rates over a decade]
[References]
- Swiss Re Research Institute (2024). [Enrichment Data]Strategic Insights: Regulatory Perspectives.
- Research Square (2024). Alessandria et al. Identification and Characterization of Dangerous Contaminants in Pfizer's COVID-19 mRNA Vaccine.
- Swiss Re Research Institute (2024). Rodrigues and Andrade. The Impact of mRNA COVID-19 Vaccines on Death Risk over Time.
- Centers for Disease Control and Prevention (2025). COVID-19 Vaccinations for Children.
- Journal of the American Medical Association (2024). Tang et al. Characterization and Evaluation of COVID-19 mRNA Vaccine Immunogenicity and Effectiveness.
- The Insurance Collaboration to Save Lives, an organization assessing life insurance claims, has identified a deterioration in life expectancy of up to 37%, which they attribute to cardiac and circulatory, neurological and nervous system, metabolic and digestive, cancer, and external causes health trends.
- A research team led by Alessandria et al and Rodrigues and Andrade suggests that mRNA vaccines could be responsible for the observed disturbing health trends, with a substantial study reporting a 37% reduction in life expectancy and increased all-cause mortality risks during a 2-year follow-up period.
- In response to escalating medical-conditions and financial losses, insurers like Cigna, Voya Financial, and Sun Life Financial are raising prices and implementing tougher policies to offset the costs, particularly in areas such as cancer treatments, infertility-related issues, and hospital care.
- The data from the insurance sector underscores a crisis in public health and mortality rates, revealing a surge in severe medical-conditions such as cancer and heart failure, which could persist for another decade, as indicated by the Swiss Re Research Institute report.
